Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9911 USD | -0.89% | +3.24% | -20.71% |
Mar. 21 | Earnings Flash (KRON) KRONOS BIO Reports Q4 Revenue $2.3M | MT |
Mar. 21 | Kronos Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 5.48M | Sales 2025 * | 3.27M | Capitalization | 60.1M |
---|---|---|---|---|---|
Net income 2024 * | -85M | Net income 2025 * | -94M | EV / Sales 2024 * | 5.4 x |
Net cash position 2024 * | 30.52M | Net Debt 2025 * | 25.18M | EV / Sales 2025 * | 26.1 x |
P/E ratio 2024 * |
-0.65
x | P/E ratio 2025 * |
-0.58
x | Employees | 63 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 77.5% |
Latest transcript on Kronos Bio, Inc.
1 week | +3.24% | ||
Current month | -23.76% | ||
1 month | -28.18% | ||
3 months | -16.01% | ||
6 months | +16.60% | ||
Current year | -20.71% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 68 | 18-03-31 | |
Joshua Kazam
FOU | Founder | 47 | 17-06-01 |
David Tanen
FOU | Founder | 52 | 17-06-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Tanen
FOU | Founder | 52 | 17-06-01 |
Joshua Kazam
FOU | Founder | 47 | 17-06-01 |
Arie Belldegrun
FOU | Founder | 74 | 17-06-01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 0.9911 | -0.89% | 281 516 |
24-04-26 | 1 | +2.04% | 442,883 |
24-04-25 | 0.98 | +2.08% | 765,478 |
24-04-24 | 0.96 | +1.05% | 904,416 |
24-04-23 | 0.95 | -1.04% | 4,308,192 |
Delayed Quote Nasdaq, April 29, 2024 at 01:33 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.71% | 60.1M | |
+2.52% | 42.75B | |
+47.70% | 41.61B | |
+12.06% | 41.34B | |
-8.83% | 26.59B | |
+6.99% | 25.49B | |
-22.61% | 18.12B | |
+30.39% | 12.24B | |
-2.15% | 11.76B | |
+9.12% | 11B |
- Stock Market
- Equities
- KRON Stock